PPT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.698200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.319600E-01
Normal-vs-Stage2
4.164800E-01
Normal-vs-Stage3
9.137800E-01
Normal-vs-Stage4
3.769600E-01
Stage1-vs-Stage2
4.201000E-01
Stage1-vs-Stage3
2.214400E-01
Stage1-vs-Stage4
9.467000E-01
Stage2-vs-Stage3
4.001000E-01
Stage2-vs-Stage4
5.748800E-01
Stage3-vs-Stage4
3.618600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.618200E-01
Normal-vs-AfricanAmerican
3.762400E-01
Normal-vs-Asian
4.843600E-01
Caucasian-vs-AfricanAmerican
6.839600E-02
Caucasian-vs-Asian
6.335000E-01
AfricanAmerican-vs-Asian
5.715400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.976400E-01
Normal-vs-Female
3.492400E-01
Male-vs-Female
4.086200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.234430E-01
Normal-vs-Age(41-60Yrs)
2.563400E-01
Normal-vs-Age(61-80Yrs)
4.848200E-01
Normal-vs-Age(81-100Yrs)
1.569640E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.921600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.232600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.254980E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.520400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.962600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.909000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.344600E-01
Normal-vs-Daily Drinker
7.295600E-01
Normal-vs-Weekly Drinker
1.842810E-01
Normal-vs-Occasional Drinker
3.926400E-01
Normal-vs-Social Drinker
2.995200E-01
Non Drinker-vs-Daily Drinker
4.234800E-01
Non Drinker-vs-Weekly Drinker
1.577430E-01
Non Drinker-vs-Occasional Drinker
2.928000E-01
Non Drinker-vs-Social Drinker
2.899800E-01
Daily Drinker-vs-Weekly Drinker
6.526300E-02
Daily Drinker-vs-Occasional Drinker
1.458190E-01
Daily Drinker-vs-Social Drinker
1.310250E-01
Weekly Drinker-vs-Occasional Drinker
9.518800E-01
Weekly Drinker-vs-Social Drinker
8.139400E-01
Occasional Drinker-vs-Social Drinker
8.057800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.675400E-01
Normal-vs-Grade 2
9.956200E-01
Normal-vs-Grade 3
9.936600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.540400E-01
Grade 1-vs-Grade 3
2.754800E-01
Grade 1-vs-Grade 4
7.675400E-01
Grade 2-vs-Grade 3
9.647400E-01
Grade 2-vs-Grade 4
9.956200E-01
Grade 3-vs-Grade 4
9.936600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.182600E-01
Normal-vs-NonDiabetic
3.646800E-01
Diabetic-vs-NonDiabetic
7.907600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.498600E-01
Normal-vs-NoPancreatitis
3.998800E-01
Pancreatitis-vs-NoPancreatitis
9.023800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.690200E-01
Normal-vs-N1
3.946000E-01
N0-vs-N1
2.966000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.654400E-01
Normal-vs-TP53-NonMutant
3.539000E-01
TP53-Mutant-vs-TP53-NonMutant
8.351900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
